Chemopreventative Thoughts for Photodynamic Therapy

Dermatologic Clinics

Volumn 25, Issue 1, 2007, Pages 95-100

  Bissonnette, Robert ^a  

^a INNOVADERM RESEARCH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER; PHOTOSENSITIZING AGENT;

ACTINIC KERATOSIS; BASAL CELL CARCINOMA; CANCER PREVENTION; CHEMOPROPHYLAXIS; CHRONOTHERAPY; CLINICAL EFFECTIVENESS; CLINICAL STUDY; DISEASE MODEL; DRUG MECHANISM; EXPERIMENTAL STUDY; HUMAN; IMMUNE DEFICIENCY; LIGHT EXPOSURE; LIMB; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REVIEW; SKIN CANCER; TREATMENT OUTCOME; TRUNK; ULTRAVIOLET RADIATION;

AMINOLEVULINIC ACID; ANIMALS; CARCINOMA, SQUAMOUS CELL; HUMANS; KERATOSIS; MICE; NEOPLASMS, RADIATION-INDUCED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SKIN NEOPLASMS;

EID: 33751198533     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.det.2006.09.011     Document Type: Review

References (30)

1. Hamzavi I., and Lui H. Using light in dermatology: an update on lasers, ultraviolet phototherapy, and photodynamic therapy. Dermatol Clin 23 (2005) 199-207
2. Fukuda H., Casas A., and Batlle A. Aminolevulinic acid: from its unique biological function to its star role in photodynamic therapy. Int J Biochem Cell Biol 37 (2005) 272-276
3. de Gruijl F.R., and Forbes P.D. UV-induced skin cancer in a hairless mouse model. Bioessays 17 (1995) 651-660
4. de Gruijl F.R., and van der Leun J.C. Development of skin tumours in hairless mice after discontinuation of ultraviolet irradiation. Cancer Res 51 (1991) 979-984
5. Stender I.M., Beck-Thomsen N., Poulsen T., et al. Photodynamic therapy with topical delta-aminolevulinic acid delays UV photocardinogenesis in hairless mice. Photochem Photobiol 66 (1997) 493-496
6. Sharfaei S., Viau G., Lui H., et al. Systemic photodynamic therapy with aminolevulinic acid delays the appearance of ultraviolet-induced skin tumours in mice. Br J Dermatol 144 (2001) 1207-1214
7. Liu Y., Viau G., and Bissonnette R. Multiple large-surface photodynamic therapy sessions with topical or systemic aminolevulinic acid and blue light in UV-Exposed hairless mice. J Cutan Med Surg 8 (2004) 131-139
8. Bissonnette R., Bergeron A., and Liu Y. Large surface photodynamic therapy with aminolevulinic acid: treatment of actinic keratoses and beyond. J Drugs Dermatol 3 (2004) S26-S31
9. Gibbs N.K., Young A.R., and Magnus I.A. A strain of hairless mouse susceptible to tumorigenesis by TPA alone: studies with 8-methoxypsoralen and solar simulated radiation. Carcinogenesis 6 (1985) 797-799
10. Juzenas P., Sharfaei S., Moan J., et al. Protoporphyrin IX fluorescence kinetics in UV-induced tumours and normal skin of hairless mice after topical application of 5-aminolevulinic acid methyl ester. J Photochem Photobiol B 67 (2002) 11-17
11. Sharfaei S., Juzenas P., Moan J., et al. Weekly topical application of methyl aminolevulinate followed by light exposure delays the appearance of UV-induced skin tumours in mice. Arch Dermatol Res 294 (2002) 237-242
12. Saldanha G., Fletcher A., and Slater D.N. Basal cell carcinoma: a dermatopathological and molecular biological update. Br J Dermatol 148 (2003) 195-202
13. Caty V., Liu Y., Viau G., et al. Multiple large surface photodynamic therapy sessions with topical methylaminolevulinate in PTCH heterozygous mice. Br J Dermatol 154 (2006) 740-742
14. Aszterbaum M., Epstein J., Oro A., et al. Ultraviolet and ionizing radiation enhance the growth of BCCs and trichoblastomas in patched heterozygous knockout mice. Nat Med 5 (1999) 1285-1291
15. Wulf HC, Pavel S, Stender IM, et al. Topical photodynamic therapy for prevention of new skin lesions in renal transplant recipients. Presented at the 13th Congress of the European Academy of Dermatology and Venereology (EADV), Florence, Italy, November 18-24, 2004.
16. de Graaf Y.G., Kennedy C., Wolterbeek R., et al. Photodynamic therapy does not prevent cutaneous squamous-cell carcinoma in organ-transplant recipients: results of a randomized-controlled trial. J Invest Dermatol 126 (2006) 569-574
17. Dragieva G., Prinz B.M., Hafner J., et al. A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipients. Br J Dermatol 151 (2004) 196-200
18. Oseroff A. PDT as a cytotoxic agent and biological response modifier: implications for cancer prevention and treatment in immunosuppressed and immunocompetent patients. J Invest Dermatol 126 (2006) 542-544
19. Wennberg AM, Keohane S, Lear JT. A multicenter study with MAL-PDT cream in immuno-compromised organ transplant recipients with non-melanoma skin cancer. Poster presented at the European Academy of Dermatology and Venereology (EADV) meeting, London, October 13-16, 2005.
20. Oseroff A.R., Shieh S., Frawley N.P., et al. Treatment of diffuse basal cell carcinomas and basaloid follicular hamartomas in nevoid basal cell carcinoma syndrome by wide-area 5-aminolevulinic acid photodynamic therapy. Arch Dermatol 141 (2005) 60-67
21. Itkin A., and Gilchrest B.A. delta-Aminolevulinic acid and blue light photodynamic therapy for treatment of multiple basal cell carcinomas in two patients with nevoid basal cell carcinoma syndrome. Dermatol Surg 30 (2004) 1054-1061
22. Chapas A.M., and Gilchrest B.A. Broad area photodynamic therapy for treatment of multiple basal cell carcinomas in a patient with nevoid basal cell carcinoma syndrome. J Drugs Dermatol 5 2 Suppl (2006) 3-5
23. Angell-Petersen E., Sorensen R., Warloe T., et al. Porphyrin formation in actinic keratosis and basal cell carcinoma after topical application of methyl 5-aminolevulinate. J Invest Dermatol 126 (2006) 265-271
24. Fritsch C., Homey B., Stahl W., et al. Preferential relative porphyrin enrichment in solar keratoses upon topical application of aminolevulinic acid methylester. Photochem Photobiol 68 (1998) 218-221
25. Peng Q.A., Warloe T., Moan J., et al. Distribution of 5-aminolevulinic acid-induced porphyrins in noduloulcerative basal cell carcinoma. Photochem Photobiol 62 (1995) 906-913
26. Rittenhouse-Diakun K., Van Leengoed H., Morgan J., et al. The role of transferrin receptor (CD71) in photodynamic therapy of activated and malignant lymphocytes using the heme precursor delta-aminolevulinic acid (ALA). Photochem Photobiol 61 (1995) 523-528
27. Berg J.W.R., van Kranen H.J., and Rebel H.G. Early p53 alterations in mouse skin carcinogenesis by UVB radiation: immunohistochemical detection of mutant p53 protein in clusters of preneoplastic epidermal cells. Proc Natl Acad Sci U S A 93 (1996) 274-278
28. Canti G., De Simone A., and Korbelik M. Photodynamic therapy and the immune system in experimental oncology. Photochem Photobiol Sci 1 (2002) 79-80
29. Gollnick S.O., Musser D.A., Oseroff A.R., et al. IL-10 does not play a role in cutaneous photofrin photodynamic therapy-induced suppression of the contact hypersensitivity response. Photochem Photobiol 74 (2001) 811-816
30. Gollnick S.O., Evans S.S., Baumann H., et al. Role of cytokines in photodynamic therapy-induced local and systemic inflammation. Br J Cancer 88 (2003) 1772-1779